Neoplasms, Colorectal Completed Phase Trials for Regorafenib (DB08896)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

DBCOND0036298 (Neoplasms, Colorectal)CompletedNot Available IdentifierTitlePurposeDrugs
NCT02106858Stivarga Regulatory Post-Marketing Surveillance Study in Korea
NCT01843400Regorafenib Post-marketing Surveillance
NCT02347852Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer
NCT03386825Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib
NCT02656524Stivarga Real Life Evidence in Hungary
NCT01959269Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy